pyrroles has been researched along with Conus Medullaris Syndrome in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agerbaek, M; Donskov, F; Fode, K; Folkmar, TB; Smidt-Hansen, T | 1 |
| Adeduntan, R; Antoni, D; Noël, G; Paix, A; Waissi, W | 1 |
| Cardinal, E; Gallina, A; Karakiewicz, PI; Perrotte, P; Saad, F; Trinh, QD | 1 |
1 review(s) available for pyrroles and Conus Medullaris Syndrome
| Article | Year |
|---|---|
Visceral and bone metastases of a WHO grade 2 meningioma: A case report and review of the literature.
Topics: Adult; Antineoplastic Agents; Bone Neoplasms; Combined Modality Therapy; Female; Humans; Ilium; Indoles; Liver Neoplasms; Lung Neoplasms; Magnetic Resonance Imaging; Meningeal Neoplasms; Meningioma; Neoplasm Grading; Pyrroles; Radiotherapy, Adjuvant; Radiotherapy, Intensity-Modulated; Ribs; Spinal Cord Compression; Spinal Neoplasms; Spine; Sunitinib | 2017 |
2 other study(ies) available for pyrroles and Conus Medullaris Syndrome
| Article | Year |
|---|---|
Combination of zoledronic Acid and targeted therapy is active but may induce osteonecrosis of the jaw in patients with metastatic renal cell carcinoma.
Topics: Adult; Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bevacizumab; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Bone Neoplasms; Carcinoma, Renal Cell; Cohort Studies; Diphosphonates; Everolimus; Female; Follow-Up Studies; Fractures, Spontaneous; Humans; Imidazoles; Indazoles; Indoles; Interleukin-2; Kidney Neoplasms; Male; Middle Aged; Molecular Targeted Therapy; Niacinamide; Phenylurea Compounds; Pyrimidines; Pyrroles; Radiography, Panoramic; Retrospective Studies; Sirolimus; Sorafenib; Spinal Cord Compression; Sulfonamides; Sunitinib; Survival Rate; Zoledronic Acid | 2013 |
Sunitinib relieves renal cell carcinoma spinal cord compression.
Topics: Aged; Antineoplastic Agents; Carcinoma, Renal Cell; Female; Humans; Indoles; Kidney Neoplasms; Pyrroles; Spinal Cord Compression; Spinal Neoplasms; Sunitinib | 2007 |